Size matters: Bimodal imaging receives nanoparticle enhancement Science and Technology of Advanced Materials Mar 10, 2021 21:00 JST Read More
NEC Joins the CONNECT Landmark Public-private Initiative for Precision Cancer Medicine NEC Corporation Mar 08, 2021 13:28 HKT/SGT Read More
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease Eisai Mar 05, 2021 16:51 HKT/SGT Read More
エーザイ、第15回アルツハイマー・パーキンソン病学会（AD/PD2021）においてアルツハイマー病／認知症領域の開発品に関する最新データを発表 Eisai Mar 05, 2021 14:00 JST Read More
Eisai to Support Construction of Screening Framework for the Novel Coronavirus Infection in Kenya Eisai Mar 04, 2021 08:12 HKT/SGT Read More
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong Eisai Mar 02, 2021 08:06 HKT/SGT Read More
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones Avance Clinical Feb 26, 2021 17:00 JST Read More
Fujitsu and University of Toronto Researchers Develop Quantum-Inspired Technology to Optimize Radiation Treatment Plans for Brain Tumors and Other Diseases Fujitsu Ltd Feb 26, 2021 09:59 HKT/SGT Read More
在日米国商工会議所とマッキンゼー・アンド・カンパニー日本支社が、デジタル改革を通じて日本の生産性と成長を推進する11の「大胆な一手」を提案 The American Chamber of Commerce in Japan (ACCJ) Feb 25, 2021 11:30 JST Read More
Fujitsu Launches AI-powered Physical Rehabilitation Solution 'HOPE ROMREC' in Japan Fujitsu Ltd Feb 24, 2021 09:39 HKT/SGT Read More
Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090 Eisai Feb 22, 2021 14:40 HKT/SGT Read More
エーザイ、新規線維芽細胞増殖因子（FGF）受容体選択的チロシンキナーゼ阻害剤E7090が日本においてFGFR2融合遺伝子を有する切除不能な胆道がんを予定される効能・効果として厚生労働省より希少疾病用医薬品に指定 Eisai Feb 22, 2021 14:00 JST Read More
Eisai Receives Corporate Philanthropy Award for Its Efforts to Realize Human Health Care (hhc) Philosophy Eisai Feb 22, 2021 12:11 HKT/SGT Read More
